Market Overview:
The global circulating tumor cell (CTC) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of cancer, technological advancements in CTC detection and analysis, and rising demand for personalized medicine. The CTC enrichment segment is expected to grow at a higher rate than other segments during the forecast period. This can be attributed to the increasing demand for targeted therapies and growing awareness about early diagnosis and treatment of cancer. Geographically, North America is expected to dominate the global CTC market during the forecast period owing to factors such as high prevalence of cancer, well-developed healthcare infrastructure, and presence of major players in this region.
Product Definition:
A circulating tumor cell (CTC) is a cancer cell that has detached from the primary tumor and is floating in the bloodstream. CTCs can be used to monitor the progress of cancer, to predict how aggressive a tumor will be, and to help guide treatment decisions.
CTC Enrichment:
CTC enrichment is a process to isolate and culture tumor cells from the patient's blood. It has been used in cancer research for many years.
CTC Detection:
CTC detection is a new-age technology that helps in the identification of circulating tumor cells (CTCs) which are responsible for cancer metastasis. Cancer Tumor Cells or CTCs are abnormal cells that develop from normal body cells and can spread to other parts of the body.
Application Insights:
The breast cancer segment dominated the global market in 2017 owing to the increasing prevalence of breast cancer and high treatment rates. Breast cancer is one of the most common types of tumor that occurs in women, accounting for around 40% to 50% cases globally. Around 1 in 8 U.S. women develop invasive breast carcinoma at a certain point during her life, according to data published by the American Cancer Society (ACS).
In addition, there are over 200 different types of breast carcinoma known across the world with various symptoms and treatments varying from case to case depending on their location and size.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a strong research base, high healthcare expenditure and awareness levels coupled with government initiatives. For instance, as per NCI, in 2016 approximately 1 million people were diagnosed with cancer each year in U.S., out of which over 600 thousand women and 140 thousand men were diagnosed with prostate cancer annually. Thus, it is estimated that around 1 million individuals are living with this disease every year in U.S.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing incidence rates coupled with limited access & affordability for patients & their families as well as lack of skilled professionals resulting into high mortality rate associated diseases including breast.
Growth Factors:
- Increasing incidence of cancer: The incidence of cancer is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and dietary habits. This, in turn, is expected to boost the demand for CTC tests and Circulating Tumor Cell market over the forecast period.
- Growing awareness about CTC tests: There is a growing awareness among people about CTC tests and their benefits over traditional methods of diagnosis such as biopsy or surgery. This is likely to fuel the demand for Circulating Tumor Cell market in near future.
- Technological advancements: The technological advancements in detection techniques are aiding in early diagnosis of cancerous cells, which would help improve prognosis and treatment outcomes for patients suffering from cancerous tumors. This would further propel the growth of Circulating Tumor Cell market during forecast period 2017-2025 .
Scope Of The Report
Report Attributes
Report Details
Report Title
Circulating Tumor Cell Market Research Report
By Type
CTC Enrichment, CTC Detection, CTC Analysis
By Application
Breast Cancer, Prostate Cancer, Colorectal Cancer, Others
By Companies
Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm, ApoCell, Greiner Bio-one, Advanced Cell Diagnostics, Aviva Biosciences, Fluxion Biosciences, Sysmex, Epic Sciences, Cynvenio, CytoTrack, Ikonisys, Vortex BioSciences, Gilupi, Biocept, ScreenCell, ANGLE
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Circulating Tumor Cell Market Report Segments:
The global Circulating Tumor Cell market is segmented on the basis of:
Types
CTC Enrichment, CTC Detection, CTC Analysis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Cancer, Prostate Cancer, Colorectal Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Menarini-Silicon Biosystems
- Qiagen（Adnagen）
- Clearbridge Biomedics
- Celsee
- Fluidigm
- ApoCell
- Greiner Bio-one
- Advanced Cell Diagnostics
- Aviva Biosciences
- Fluxion Biosciences
- Sysmex
- Epic Sciences
- Cynvenio
- CytoTrack
- Ikonisys
- Vortex BioSciences
- Gilupi
- Biocept
- ScreenCell
- ANGLE
Highlights of The Circulating Tumor Cell Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CTC Enrichment
- CTC Detection
- CTC Analysis
- By Application:
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Circulating Tumor Cell Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A circulating tumor cell (CTC) is a cancerous cell that has spread to other parts of the body. CTCs can be found in blood, bone marrow, and other tissues.
Some of the major companies in the circulating tumor cell market are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm, ApoCell, Greiner Bio-one, Advanced Cell Diagnostics, Aviva Biosciences, Fluxion Biosciences, Sysmex, Epic Sciences, Cynvenio, CytoTrack, Ikonisys, Vortex BioSciences, Gilupi, Biocept, ScreenCell, ANGLE.
The circulating tumor cell market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Circulating Tumor Cell Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Circulating Tumor Cell Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Circulating Tumor Cell Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Circulating Tumor Cell Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Circulating Tumor Cell Market Size & Forecast, 2020-2028
4.5.1 Circulating Tumor Cell Market Size and Y-o-Y Growth
4.5.2 Circulating Tumor Cell Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 CTC Enrichment
5.2.2 CTC Detection
5.2.3 CTC Analysis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Breast Cancer
6.2.2 Prostate Cancer
6.2.3 Colorectal Cancer
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Circulating Tumor Cell Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Circulating Tumor Cell Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 CTC Enrichment
9.6.2 CTC Detection
9.6.3 CTC Analysis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Breast Cancer
9.10.2 Prostate Cancer
9.10.3 Colorectal Cancer
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 CTC Enrichment
10.6.2 CTC Detection
10.6.3 CTC Analysis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Breast Cancer
10.10.2 Prostate Cancer
10.10.3 Colorectal Cancer
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 CTC Enrichment
11.6.2 CTC Detection
11.6.3 CTC Analysis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Breast Cancer
11.10.2 Prostate Cancer
11.10.3 Colorectal Cancer
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 CTC Enrichment
12.6.2 CTC Detection
12.6.3 CTC Analysis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Breast Cancer
12.10.2 Prostate Cancer
12.10.3 Colorectal Cancer
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 CTC Enrichment
13.6.2 CTC Detection
13.6.3 CTC Analysis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Breast Cancer
13.10.2 Prostate Cancer
13.10.3 Colorectal Cancer
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Circulating Tumor Cell Market: Competitive Dashboard
14.2 Global Circulating Tumor Cell Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Menarini-Silicon Biosystems
14.3.2 Qiagen（Adnagen）
14.3.3 Clearbridge Biomedics
14.3.4 Celsee
14.3.5 Fluidigm
14.3.6 ApoCell
14.3.7 Greiner Bio-one
14.3.8 Advanced Cell Diagnostics
14.3.9 Aviva Biosciences
14.3.10 Fluxion Biosciences
14.3.11 Sysmex
14.3.12 Epic Sciences
14.3.13 Cynvenio
14.3.14 CytoTrack
14.3.15 Ikonisys
14.3.16 Vortex BioSciences
14.3.17 Gilupi
14.3.18 Biocept
14.3.19 ScreenCell
14.3.20 ANGLE
